Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
BioSuperior
company
About
BioSuperior is a preclinical stage biotherapeutics firm that develops technologies to cure lung disease and repair damaged lung tissue.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $255.98K
- Industries
- Biotechnology,Information Technology,Life Science,Medical,Medical Device
- Founded date
- Jan 1, 2017
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$255.98K
BioSuperior has raised a total of
$255.98K
in funding over 2 rounds. Their latest funding was raised on
Jun 17, 2022 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 17, 2022 | Grant | $255.98K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
BioSuperior is funded by 1 investors.
National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
